Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Roncati, Luca, Roncati, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Palgrave Macmillan UK 2021
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314028/
https://www.ncbi.nlm.nih.gov/pubmed/34316006
http://dx.doi.org/10.1057/s41271-021-00299-6
_version_ 1783729466127679488
author Roncati, Luca
Roncati, Monica
author_facet Roncati, Luca
Roncati, Monica
author_sort Roncati, Luca
collection PubMed
description
format Online
Article
Text
id pubmed-8314028
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Palgrave Macmillan UK
record_format MEDLINE/PubMed
spelling pubmed-83140282021-07-27 Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic Roncati, Luca Roncati, Monica J Public Health Policy Letter to the Editors Palgrave Macmillan UK 2021-07-27 2021 /pmc/articles/PMC8314028/ /pubmed/34316006 http://dx.doi.org/10.1057/s41271-021-00299-6 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editors
Roncati, Luca
Roncati, Monica
Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title_full Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title_fullStr Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title_full_unstemmed Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title_short Emergency use authorization (EUA), conditional marketing authorization (CMA), and the precautionary principle at the time of COVID-19 pandemic
title_sort emergency use authorization (eua), conditional marketing authorization (cma), and the precautionary principle at the time of covid-19 pandemic
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314028/
https://www.ncbi.nlm.nih.gov/pubmed/34316006
http://dx.doi.org/10.1057/s41271-021-00299-6
work_keys_str_mv AT roncatiluca emergencyuseauthorizationeuaconditionalmarketingauthorizationcmaandtheprecautionaryprincipleatthetimeofcovid19pandemic
AT roncatimonica emergencyuseauthorizationeuaconditionalmarketingauthorizationcmaandtheprecautionaryprincipleatthetimeofcovid19pandemic

Ejemplares similares